McDonald's stock has declined 20.6% in 2026, trading 29% below its 52-week high, making it one of the worst Dow performers. However, the company's 3.2% dividend yield, 50-year consecutive dividend increase streak (Dividend King status), and new NEXT strategic plan focusing on AI, store revamps, and menu simplification may present a buying opportunity for patient investors seeking inflation-hedging dividend growth.
MCD
McDonald's Corporation · NYSE
Sign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about MCD?
Latest news
News ›McDonald's (MCD) closed at $246.52, up 1.59% for the day but down 2.1% over the past month, underperforming its sector. The company holds a Zacks Rank #4 (Sell) rating despite trading at a Forward P/E of 18.9, below its industry average of 20.83. Upcoming earnings on November 4, 2026 are expected to show EPS growth of 4.66% and revenue growth of 2.88% year-over-year.
McDonald's is set to become a Dividend King with 50+ consecutive years of dividend increases. Despite a 20.5% year-to-date stock decline, the company offers an attractive 3.2% dividend yield and a compressed valuation (P/E of 19.7).
Its franchise model generates predictable cash flow, though weak same-store sales growth and consumer spending pressures remain concerns. McDonald's is investing $8.5 billion over 10 years to drive long-term growth and market share.
Headlines link to the publisher. Not investment advice.
Board · 0 threads
Open board ›No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Board · $MCD · 0 threads
Sign in to post on $MCD
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.